Related by context. All words. (Click for frequent words.) 73 NCEs 68 nitric oxide donating 67 anti infective treatments 66 NuMimetic TM 65 targeted radiotherapeutic 65 Provectus Pharmaceuticals specializes 65 HepDirect R 65 novel antibody therapeutics 65 ionotropic glutamate receptor antagonists 65 muscarinic receptor agonist 65 adrenergic regulation 65 THR beta agonist 65 rxRNA 65 Technology LVT 65 Cotara R 64 tiapamil 64 oncolytic virus therapies 64 AFREZZA TM 64 Ganciclovir 64 KL4 Surfactant 64 PDE4 inhibitor 64 vapreotide acetate 64 therapeutic monoclonal antibodies 64 Factor VIIa 64 Panzem ® 64 selective immunoproteasome inhibitor 64 XmAb ™ 64 Nanobody 64 proprietary Lipid Vector 64 Pentad TM 64 using VIAdel TM 64 PORxin TM platforms 64 Captisol ® 64 SYCREST 64 liposomal delivery 64 recombinant biopharmaceutical 64 humanized monoclonal 63 Zemiva TM 63 POTELLIGENT ® 63 Aganocide 63 toenail onychomycosis 63 Locked Nucleic Acid 63 DUROS 63 Myocet 63 methylnaltrexone bromide 63 ALN PCS 63 Onalta TM 63 FOLOTYN ® 63 isoform selective 63 Panzem R 63 novel anti infective 63 Zorbtive TM 63 proprietary PEGylation 63 patented Bioral 63 Recombinant Human 63 acetonide FA 63 Liprotamase 63 antisense inhibitor 63 HCV protease inhibitors 63 oral ghrelin agonist 63 PORxin TM 63 including eniluracil ADH 63 Ecallantide 63 TRANSDUR ™ 63 Selective Electrochemical Tumor Ablation 63 mertansine 63 selective adenosine 63 NeuroSTAT ® 63 Saizen R 63 Alfacell proprietary ribonuclease 63 chemical entities NCEs 63 Enhanze 62 Lubiprostone 62 HCV polymerase 62 Initiate Clinical Trial 62 HuCAL GOLD R 62 Adnectin 62 peptide conjugated 62 monoclonal antibody MAb 62 MKC# MKC# PP 62 Marqibo TM 62 product Fentanyl TAIFUN 62 tubulin inhibitor 62 GIPET 62 Dapagliflozin 62 Oral Spray 62 gastro intestinal inflammation 62 Files IND 62 DermaPrep 62 oral prodrug 62 taxane derivative 62 Chemokine Receptor 62 SMaRT ™ 62 motexafin gadolinium Injection 62 GTC recombinant human 62 INS# [001] 62 Civacir 62 RECOTHROM R 62 Initiates Clinical 62 Qutenza TM 62 Neulasta R 62 small molecule PEGylation 62 MTP inhibitor 62 VISICOL R 62 therapeutic monoclonal antibody 62 DPX Survivac 62 diarrhea predominant irritable 62 HuMax TAC 62 ALN TTR 62 MOVIPREP R 62 topically applied SEPA 62 Tarmogen 62 Prodarsan R 62 Nanobody ® 62 Bucindolol 62 Viprovex R 62 HuMax 62 muscarinic receptor agonists 62 small molecule thrombopoietin 62 gets USFDA nod 62 Doripenem 62 Homspera TM 62 novel antiviral therapeutics 62 molecular imaging radiopharmaceutical 62 AdVac R 62 Reports Preclinical Data 62 antisense inhibitors 62 Iluvien ® 62 oral proteasome inhibitor 62 candidates Azedra 62 CD# monoclonal antibody 62 ophthalmology oncology 62 NTDDS 62 SPL# Gel vaginal microbicide 62 Initiates Clinical Trial 61 Pancreate 61 Intravenous Human 61 XmAb 61 kidney urologic 61 Lixivaptan 61 orally inhaled 61 candidates Azedra TM 61 biologic therapeutics 61 Aerosurf 61 Transdel TM platform 61 DP VPA 61 Micromet proprietary BiTE 61 PGL# 61 novel peptides 61 potently inhibit 61 platinum chemotherapeutic 61 POTELLIGENT R 61 Safinamide 61 JAK2 Inhibitor 61 Ostabolin C TM 61 transmucosal delivery 61 HepaGam B 61 Initiates Enrollment 61 topical anti infective 61 LEUKINE 61 TÎ ² 4 61 novel therapeutic antibodies 61 Therapeutic Competitors Companies 61 Firazyr 61 utilizes InSite Vision 61 developing TB4 61 Surfaxin LS 61 novel synthetic peptide 61 cathepsin K inhibitor 61 Atripla combines 61 Crofelemer budesonide foam 61 purinergic receptors P#X# 61 proprietary albumin fusion 61 SuperAntibody 61 investigational humanized monoclonal antibody 61 recombinant antibodies 61 HepDirect prodrug 61 products Oncaspar 61 XmAb TM 61 miRNA therapeutics 61 RONDEL ™ 61 Archexin 61 NanoTab 61 CCR9 antagonist 61 Maxy G# 61 EHT AGN 61 Cyclosert TM 61 metaglidasen 61 Locked Nucleic Acid LNA 61 investigational pan BCR 61 JAK2 inhibitor 61 P#X# antagonist 61 anti CD3 monoclonal 61 BrachySil TM 61 ALTROPANE R 61 Cyclosporin 61 recombinant adeno associated 61 wilate ® 61 SomatoKine 61 Glypromate 61 RECOTHROM ® 61 novel VDA molecule 61 antimitotic 61 histone deacetylase HDAC inhibitor 61 optical biosensors 61 candidate deforolimus 61 Vidofludimus 61 Boniva ibandronate 61 DiLA2 61 GW# [003] 61 brand ciclesonide HFA 61 Ralivia TM 61 introduced NEUGENE 61 Oracea TM 61 IMiDs ® 61 acyclovir Lauriad R 61 Therapeutic Vaccine 61 Panzem 61 adenosine A2A 61 Inhalation Aerosol 61 Eraxis 61 HepeX B 61 selective androgen receptor modulators 61 dSLIM 61 rusalatide acetate 61 Drug Candidate 61 COLAZAL R 61 PEGylated interferon 61 aripiprazole Abilify 61 ERYtech 61 Monoclonal antibody 61 SinuNase ™ 60 Unit Dose Budesonide 60 proprietary BiTE ® 60 Protein Expression 60 Therapeutic Competitors companiesandmarkets.com adEgemonye 60 Saizen ® 60 allogeneic cell 60 Maribavir 60 Alkeran 60 lead molecular radiotherapeutic 60 Albugon 60 prostone 60 Personalized Immunotherapy 60 MDRNA proprietary 60 doxercalciferol 60 intranasal insulin product 60 investigational pharmacologically unique 60 Hemopurifier ® 60 GIPET r 60 Nexavar ® 60 candidate ridaforolimus 60 Completes Patient Enrollment 60 NurOwn 60 Fludara ® 60 IMiDs R 60 sodium thiosulfate STS 60 immunotherapeutic agent 60 AQUA ® 60 Nuron Biotech 60 phage display technology 60 histone deacetylase HDAC 60 Tesmilifene 60 rHuPH# recombinant human 60 IMPACS R 60 topically delivered 60 Small Molecule 60 fusion enhancers 60 2 methoxyestradiol 60 cardio cerebral vascular 60 orally bioavailable mimics 60 Currently RegeneRx 60 include PLX IBD 60 histone deacetylase inhibitor 60 2 inhibitor CYT# 60 NDDS 60 StaphVAX R 60 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 60 Guanilib 60 Evoltra ® 60 Curaxin 60 adalimumab Humira 60 Awarded Qualifying Therapeutic 60 Captisol 60 novel histone deacetylase 60 immunoregulation 60 Fc fusion protein 60 liposomal formulation 60 anticancer compounds 60 Enkephalin 60 GVAX ® 60 acne impetigo 60 Solazed TM 60 Inhalation Solution 60 lucinactant 60 Investigational eFlow Nebulizer System 60 Valtropin 60 VitiGam 60 candidate TNFerade biologic 60 NexACT ® 60 Augment TM 60 HIV integrase inhibitor 60 Cx# [002] 60 Medoxomil 60 vinorelbine tartrate 60 rxRNA TM compounds 60 Prodrug 60 poly ethylene glycol PEG 60 Initiates Phase II 60 intravesical instillation 60 Nautilus Biotech 60 entity NCE 60 Opterone R 60 albiglutide 60 Hsp# Inhibitor 60 PEGylation technology 60 Anticalin R 60 PERLANE 60 BioSilicon TM 60 R Saizen R 60 PROfusion 60 etanercept Enbrel 60 RhuDex ® 60 Aganocide TM 60 accumulate preferentially 60 Vascular Wrap TM 60 Achieves Primary Endpoint 60 highly selective endothelin 60 thetreatment 60 fluorinated carbohydrate mimics 60 treat chronic sinusitis 60 lipopeptide 60 Onalta 60 MassARRAY R 60 manufacturing interventional vascular 60 Yondelis ® 60 Bioral Amphotericin B. 60 JAK inhibitor 60 HepDirect technology 60 drug ISA# 60 lives manufactures RISPERDAL 60 proven DuraSite ® 60 ABL inhibitor 60 Antisense Drug 60 sirtuin therapeutics 60 CINtec R 60 novel peptide 60 proprietary biomaterials 60 Inotek Pharmaceuticals Corporation 60 prokinetic agent 60 SIX RO ROG 60 personalized cellular immunotherapy 60 Nabi HB R 60 Augment ™ 60 Genotyping Test 60 Ceflatonin R 60 PHX# 60 Supernus Pharmaceuticals 59 VentiRx Pharmaceuticals 59 Granted Orphan Drug 59 Sandimmune 59 Loramyc R 59 4SC AG ISIN DE# 59 Unigene nasal calcitonin 59 Belerofon 59 DXL TM 59 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 59 Nutra Pharma wholly owned 59 SMARTICLES 59 INxin TM 59 Saquinavir 59 HuCAL GOLD ® 59 Systemic Delivery 59 HepDirect 59 Receives Approvable Letter 59 topical dermatology 59 unique PER.C6 59 Presents Preclinical Data 59 Anidulafungin 59 Kosan dependence 59 Co Receptor Tropism 59 intranasal vaccines derived 59 Creabilis Therapeutics 59 enhance ApoA 59 vinca alkaloid 59 ADVENTRX Pharmaceuticals 59 romazarit 59 TKB# 59 Fabry Disease 59 BRILINTA 59 pralatrexate injection folate analogue 59 CYT# potent vascular disrupting 59 ZEVALIN ® 59 Kuvan TM sapropterin 59 monoclonal antibody mAb 59 vitro ADME 59 sodium glucose transporter 59 GlycArt 59 t2cure GmbH 59 outlicensed 59 Piperacillin 59 ArQule Kinase Inhibitor Platform 59 commercialize deforolimus 59 BYETTA ® 59 Aviptadil 59 ATL# [002] 59 IMiDs ® compound 59 REGiMMUNE 59 treat lupus renal 59 peptide therapeutics 59 miconazole Lauriad ® 59 selective estrogen receptor modulator 59 include Alferon N 59 Receives Orphan Drug Designation 59 Didronel 59 Rhucin ® recombinant 59 Anticalins R 59 RNAi Therapeutic 59 Roche OTC RHHBY 59 chimeric monoclonal antibody 59 renin inhibitors 59 CD# CEA 59 HyACT 59 Aganocide ® 59 Fresenius Biotech 59 HCl Tablets 59 AAG geldanamycin analog 59 Levaquin levofloxacin 59 Oral Suspension USP 59 Cerashield ™ 59 protein tyrosine phosphatase 1B 59 vivo fluorescence imaging 59 Thrombin topical Recombinant 59 Olmesartan 59 molecular radiotherapeutics 59 Pafuramidine 59 Ampakine compounds 59 BHT DNA 59 CTLA4 Ig 59 proprietary capillary aerosolization 59 MVA BN 59 Foradil Aerolizer 59 Diabetic Neuropathy 59 oral antiviral 59 Trofex 59 receptor modulators 59 Angiotensin Converting Enzyme 59 Interferon beta 59 MorphoSys proprietary 59 Aeolus Pharmaceuticals 59 EndoTAG TM 59 Squalamine 59 candidate Zemiva 59 PEGylated 59 Interferon Alpha 59 Campath ® 59 Relieva 59 peptibody 59 Prandin 59 molecular imaging pharmaceuticals 59 Besivance 59 Circ Pharma 59 Stapled Peptide 59 CYCLOSET ® 59 Vidaza R 59 investigational hepatitis C 59 RNAi Therapeutics 59 Ibis T# TM 59 Kinase Inhibitor 59 Delivery System NTDDS 59 enhanced skin permeation 59 novel RNAi therapeutics 59 Cleviprex TM clevidipine 59 cosmetic cosmeceutical products 59 Oxytrol R 59 Valganciclovir 59 PRIALT 59 epoprostenol sodium 59 FUSILEV ® 59 beta 1a 59 cancer immunotherapies 59 MolecularBreeding TM 59 oral probiotic 59 Fibroblast Growth Factor Receptor 59 Adult Stem Cell Therapy 59 JZP 59 Vitrasert R 59 SGLT Inhibitors 59 Levoleucovorin 59 therapeutic peptide 59 Polymer Microspheres 59 oncology immunology 59 product platforms AZX# 59 plasmid DNA pDNA 59 HuCAL antibodies 59 ketolide antibiotic 59 proprietary Biochronomer 59 Meets Primary Endpoint 59 FDA Approvals 59 Commercialize Novel 59 include Phenoptin TM 59 Demonstrates Significant 59 Receptos 59 Captisol enabled 59 Sanvar R 59 peptide peptide mimetic 59 Release Tablets 59 Intraosseous Infusion System 59 HTS assay 59 DispersinB ® 59 HuCNS SC ® 59 orally disintegrating 59 Xanthus Pharmaceuticals Inc. 59 YONDELIS R 59 Friedreich Ataxia FRDA 59 OncoGel 59 Receives Orphan Drug 59 OMNARIS Nasal Spray 59 nasal calcitonin product 59 ZFP Therapeutics 59 R#/MEM 59 Medisorb R 59 INOmax R 59 Serdolect ® 59 Sapacitabine 59 Announces Tentative Approval 59 Antithrombin 59 TRISENOX R arsenic trioxide 59 Medarex UltiMAb 59 Shigamabs ® 59 NB S# strontium malonate 59 PREOS R 59 deCODE chemistry 59 Restoraderm 59 Aldara ® 59 anticoagulant reversing agent 59 anti infective 59 virosome 59 Nivestim 59 delipidation 59 Medarex UltiMAb R 59 Alvesco R 59 reslizumab 59 biosurgical 59 Orally administered 59 oral renin inhibitor 59 orally bioavailable 59 Gamunex C 59 lexidronam injection 59 antisense drug 59 Carbidopa Levodopa 59 NeutroPhase TM 59 Mycophenolate Mofetil 59 Tracleer ® 59 immunotherapeutic approaches 59 predictive toxicology 59 subsidiaries visit http:/www.apricusbio.com 59 aerosolized AAT 59 nasally delivered 59 Liposomal 59 microtubule inhibitor 59 AzaSite Xtra 59 Thrombin 59 Nasdaq HALO biopharmaceutical 59 Files Investigational 59 Novosom 59 delivers sumatriptan 59 CORTOSS R 59 vitreoretinal disorders 59 recombinant subunit vaccine 59 AKT inhibitor 58 Emollient Foam 58 ELADUR ™ 58 ALVESCO ® 58 Hexvix ® 58 metabolically inert oral antifolate 58 Orphan Drug designations 58 ® daptomycin 58 Serostim R 58 MP4 molecule 58 neuro inflammatory 58 First Patient Dosed 58 intravenous AAT 58 Cethrin R 58 Euroscreen 58 Initiates Dosing 58 hepatitis B immune globulin 58 immunodiagnostics 58 KL4 surfactant 58 derivatives Radilex TM 58 ARRY # 58 Present Preclinical Data 58 SinuNase TM 58 anti CD3 58 FS Antihemophilic Factor Recombinant 58 Shows Promise Against 58 humanized anti 58 Aptamer 58 ViroChem 58 Kuvan sapropterin dihydrochloride 58 ATG Fresenius S 58 Ophthotech 58 Abbokinase 58 Insugen 58 Wafer polifeprosan 58 ENMD # 58 Combivir Kivexa 58 Tumour Vascular Disrupting Agent 58 beta islets 58 candidate REP# 58 Onconase 58 QUADRAMET R 58 Immunotherapeutic 58 Hematopoietic 58 NovaBay Aganocide compounds 58 XL# XL# 58 Interferon alpha 58 commercializing anti infective 58 orthobiologic 58 PRN FDA Approves 58 AERx ® 58 polymer conjugate technology 58 HepeX B TM 58 patented NanoStat ™ 58 Microplasmin 58 Captisol Enabled 58 polymerase inhibitors 58 protein biochip 58 include Altastaph TM 58 recombinant antibody 58 UltiMAb 58 PROSTASCINT R 58 Perflubutane Polymer Microspheres 58 VALSTAR 58 Traficet EN 58 IAP inhibitors 58 Fleximer 58 Dural Regeneration Matrix 58 Pimavanserin 58 Cathepsin S 58 RECALL VAX 58 Inc. dba Vitro 58 TNF Tumor Necrosis Factor 58 Nanobody R 58 oral taxane 58 commercializing therapeutic 58 HCV protease inhibitor 58 BACcel 58 TG# [003] 58 ospemifene 58 therapeutic radiopharmaceuticals 58 INSPIRE Trial Phase III 58 Indomethacin 58 anti CD# antibodies 58 protein kinase inhibitors 58 vaccine GRNVAC1 58 ONCASPAR 58 Akebia Therapeutics 58 Protein Kinase C 58 Viprovex TM 58 Receptors GPCRs 58 BCR ABL inhibitors 58 ACTCellerate 58 CB2 selective 58 Antibody Drug Conjugate 58 inflammatory autoimmune diseases 58 ImmunoCellular Therapeutics 58 mesylate tablets 58 HuMax HepC TM 58 CDP# 58 POSIDUR TM ELADUR TM 58 antiangiogenesis therapies 58 polyclonal antibodies 58 vaccines oncolytic virus 58 Anti infective 58 Iluvien TM 58 COX Inhibiting Nitric Oxide 58 Urocidin TM 58 Fx #A 58 Azedra 58 MicroDose 58 hypereosinophilic syndrome 58 DOS# 58 AMITIZA ® 58 rThrombin 58 ASONEP TM 58 Elagolix 58 PEGylated anti 58 antibiotics antifungals 58 telomerase inhibitor drug 58 RNA antagonists 58 targeted antifolate 58 asthma COPD Chronic 58 topical non steroidal 58 Proquin XR 58 commercialize ZYFLO CR 58 NYSE Amex PBTH 58 oral dihydropyrimidine dehydrogenase DPD 58 GSK '# 58 Aloprim TM allopurinol sodium 58 Oxytrex TM 58 pharmacological chaperone 58 sumatriptan DosePro 58 generation NEUGENE antisense 58 RELOVAIR ™ 58 pan HDAC inhibitor 58 Tumor Necrosis Factor 58 MetroGel 58 KSP inhibitor 58 Mycograb 58 Prednisporin 58 commercialize becocalcidiol patented 58 Gastrointestinal Liner 58 Kristalose ® lactulose 58 molecular imaging radiopharmaceuticals 58 Simulect 58 Surgical Sealant 58 Zenapax 58 IL# PE#QQR 58 BXT # 58 platform HDL Mimetic 58 XmAb ® 58 immunotherapeutic vaccine 58 Neulasta ® 58 Rebif ® 58 NovaDel oral spray 58 Testim R 58 RxKinetix 58 novel oral anticoagulant 58 lipid nanoparticle 58 Tarvacin TM 58 Restoraderm R 58 Exjade deferasirox 58 mesylate 58 IV Busulfex 58 novel immunotherapies 58 Novasomes 58 selective orally bioavailable 58 Glucophage R 58 liposome formulations 58 Pertuzumab 58 Dual Opioid TM 58 HuCAL PLATINUM ® CysDisplay 58 immunomodulators 58 Idera Pharmaceuticals 58 Preclinical Data 58 Therapeutic Antibody 58 Pazopanib 58 treat male hypogonadism 58 Prolongs Survival 58 Alvesco ® 58 humanized antibody 58 biotherapeutic drugs 58 Filgrastim 58 R DepoCyt 58 Granulocyte Colony Stimulating Factor 58 Pirfenidone 58 ATD gel 58 Prometheus Laboratories 58 PNP inhibitor 58 commercialize XP# 58 GEM OS2 58 epoetin zeta 58 TFChem licenses 58 ProNAi 58 sapropterin dihydrochloride 58 FDA APPROVES 58 Scaffold Based 58 Sudhir Agrawal D.Phil 58 MCSP respectively 58 agonistic human 58 hypoxia activated prodrug 58 RELISTOR ® 58 Dexilant 58 Demonstrates Potential 58 bioerodible 58 oral salmon calcitonin 58 non nucleoside inhibitor 58 delivery polymer matrix 58 Therapeutic Competitors Report 58 Intravenous CP 58 humanized monoclonal antibodies 58 Transdermal Delivery 58 VivaGel ™ 58 SARMs 58 Nanobodies ® 58 rheumatoid arthritis thrombocytopenia 58 MGd 58 ELND-#/AZD-# 58 CD# antibody [001] 58 Intravesical 58 Dendritic Cells 58 stable nucleic acid 58 intravesical infusion therapy 58 vaginally administered lidocaine 58 dermatology therapies 58 GA GCB 58 non nucleoside HCV 58 diagnostic molecular imaging 58 HDL Mimetic Peptide 58 Successfully Completes Phase 58 recombinant polyclonal antibodies 58 Drug Absorption 58 Microspheres 58 Adrenomyeloneuropathy AMN HIV 58 Activity Assay 58 TPI ASM8 58 Regenerative Cells 58 Alvine Pharmaceuticals 58 Loramyc ® 58 BiTE 58 Phase III Clinical Trial 58 siRNAs targeting 58 Prolexys 58 GPR# agonist 58 PDE# inhibitors 58 ENTOCORT EC 58 PharmaVitae Profile 58 Novel Oral 58 candidate epratuzumab 58 NEUGENE R 58 Octreotide 58 Ampligen ® 58 topical ophthalmic 58 catalytic antioxidant compounds 58 transfection reagents 58 autoimmune inflammatory 58 proteasome inhibitor 58 Quinamed 58 sd rxRNA 57 Benazepril 57 #D#C# 57 TRACON Pharmaceuticals 57 miRview meso 57 Adenosine Therapeutics 57 small molecule glucokinase 57 buccal spray 57 ATL/TV# 57 Platelet Derived Growth 57 commercialize Aganocides 57 dermatological diseases 57 Aliskiren 57 mda 7 57 commercializing novel biotherapeutics 57 Suven 57 ELADUR TM 57 Topical Suspension 57 EP #R 57 Ercole Biotech 57 Bioral 57 receptor tyrosine kinase inhibitor 57 immunotoxins 57 vivo validation 57 GeneICE 57 CTAP# Capsules 57 Angiocept 57 highly selective inhibitor 57 liver resection surgeries 57 IAP inhibitor 57 tazarotene 57 Retacrit 57 HCV Protease Inhibitor 57 DiscoveRx 57 DiaPep# 57 pigmentary disorders 57 Droxidopa Chelsea 57 3 kinase PI3K 57 patented NanoStat TM 57 Nascobal 57 adenovector 57 delivers fluocinolone acetonide FA 57 Coapt 57 Endotoxin Activity Assay 57 AKIP ™ 57 ZFP TF 57 Fenoglide 57 GlycoPEGylated hemostasis compounds 57 myelofibrosis polycythemia vera 57 PrevOnco 57 Dalbavancin 57 Fortical R 57 diagnostic radiopharmaceutical 57 Chimigen 57 Elvitegravir 57 Epidermal Growth Factor Receptor 57 Cardio Vascu Grow 57 Bavarian Nordic patented 57 FACTIVE R gemifloxacin 57 small molecule activators 57 Dasatinib 57 parenterally administered 57 HCl Injection 57 Pepducin 57 investigational protease inhibitor 57 Oral Insulin 57 Raptiva R 57 Sumatriptan Succinate 57 humanised monoclonal antibody 57 either acutely decompensated 57 HQK 57 Alnylam #x# 57 CORT # 57 ThermoDox R 57 MYCAMINE 57 Cyclosert 57 Somatuline Depot 57 Phase III Clinical Trials 57 MEDA AB publ 57 recombinant factor VIIa 57 TLR Therapeutics 57 encapsulated porcine insulin 57 Mipomersen 57 vascular disrupting agents 57 EndoTAG 57 Cimzia certolizumab pegol 57 BC SeraPro proteomic 57 CEQ# 57 BENLYSTA ® 57 Milnacipran 57 NeutroSpec TM 57 OTCBB NPHC biotechnology 57 Nexavar sorafenib tablets 57 Submits NDA 57 Methylnaltrexone 57 DPP4 inhibitor 57 Alinia 57 SURFAXIN 57 OPi 57 NNR Therapeutics 57 SNALP technology 57 Sufentanil 57 LEAD Therapeutics 57 Spiegelmer 57 Chemetics R 57 Kineret R 57 Oral Formulation 57 Factor Receptor 57 BUPHENYL R 57 VYVANSE TM lisdexamfetamine 57 Capsulution 57 synthetic siRNA 57 Xenazine ® 57 TELINTRA R 57 mucositis ProLindac ™ 57 biobetter 57 Esmya 57 cytomegalovirus immune globulin 57 Alferon LDO 57 Lysteda 57 rxRNA ™ compounds 57 Glatiramer Acetate 57 NEUGENE 57 Sitagliptin 57 HuLuc# 57 PEGylation 57 NITD 57 oral Azacitidine 57 Transdermal Patch 57 SEASONALE R 57 Taligen Therapeutics 57 miconazole Lauriad R 57 Nabi HB ® 57 mRNA antagonists 57 Novel Antibiotic 57 Deferiprone 57 LNP formulations 57 IMiD 57 Cellcept 57 Oasmia 57 Novel Antibody 57 HP Acthar R 57 Levulan ® PDT 57 ® bortezomib 57 rhFVIIa 57 PAION AG ISIN 57 volociximab 57 Survivin antagonist 57 NS#/#A protease 57 psoriasis rheumatoid arthritis 57 synthetic ligand affinity 57 telomerase therapeutic 57 VEGF inhibitors 57 sublingual tablets 57 Galenea 57 Plexxikon proprietary 57 carbapenem 57 immune modulator 57 Enanta Pharmaceuticals 57 salmon calcitonin 57 Abstral ® 57 Gleevec imatinib mesylate 57 COMPLEGENT TM Technologies 57 Tiazac 57 LibiGel ® 57 Atopic Dermatitis 57 Aurora Kinase 57 Prodarsan ® 57 buccal delivery 57 Cefepime